Clinical Trials Logo

Atrial Fibrillation or Flutter clinical trials

View clinical trials related to Atrial Fibrillation or Flutter.

Filter by:
  • None
  • Page 1

NCT ID: NCT02454283 Terminated - Clinical trials for Atrial Fibrillation or Flutter

Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm

RESTORE SR
Start date: September 2015
Phase: Phase 3
Study type: Interventional

LGN-VN-003 is a prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation (AF) or atrial flutter (AFL) to normal sinus rhythm. Up to 625 subjects will be randomized in a 2:1 fashion so at least 400 vanoxerine and 200 placebo subjects receive study drug.